Janus Living Upgraded to Buy, Shares Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 15 2024
0mins
Should l Buy JAN?
Source: NASDAQ.COM
Janus Living (JAN) shares rose 7.13% to reach a 52-week high amid positive analyst ratings.
The stock's increase follows a Buy rating initiation by BofA Securities and an Overweight rating from KeyBanc Capital Markets, reflecting strong market optimism about JAN's growth potential in the senior housing sector. Analysts expect normalized FFO estimates of $0.96 per share for 2026 and $1.13 for 2027, both surpassing consensus estimates, indicating a robust profitability outlook.
This rating upgrade positions Janus Living favorably in the market, suggesting that the company is well-equipped to capitalize on growth opportunities in the senior housing industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy JAN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on JAN
Wall Street analysts forecast JAN stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 26.470
Low
Averages
High
Current: 26.470
Low
Averages
High
About JAN
ALT5 Sigma Corporation is a fintech company providing blockchain-powered technologies for tokenization, trading, clearing settlement, payment and safe keeping of digital assets. The Company, through its subsidiary, ALT5 Sigma, Inc., provides blockchain-powered technologies to enable migration to a global financial paradigm. It offers two platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. The Company also owns Mswipe, which is a payment solutions provider offering multi-currency, fiat payment card services along with crypto-enabled capabilities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of High-Yield Stocks in Healthcare Sector
- Perrigo's High Yield and Risks: With a forward dividend yield of 9.6%, Perrigo's stock has plummeted over 87.5% in the past decade, indicating the uncertainty behind its high yield, which investors must carefully assess as a potential value trap.
- Healthpeak's Restructuring Potential: As one of the largest healthcare REITs, Healthpeak Properties owns over 700 healthcare-related properties, currently offering a forward dividend yield of 7.1%, and its newly formed Janus Living could enhance its market value, attracting investors focused on capital growth.
- Dividend Cuts at Medical Properties Trust: Medical Properties Trust has a forward dividend yield of approximately 6.8%, but it has reduced its dividend twice due to the bankruptcy of major tenant Steward Health Care, highlighting its financial challenges.
- Financial Stability and Future Outlook: Despite facing tenant financial issues and over $2 billion in debt maturities, Medical Properties Trust's latest quarterly results show normalized funds from operations of $0.18 per share, suggesting it can sustain its current dividend for now.
See More
Janus Living Initiated with Buy Ratings, Shares Rise
- Rating Upgrade: Janus Living (JAN) was initiated with a Buy rating by BofA Securities and an Overweight rating by KeyBanc Capital Markets, resulting in a 2.58% increase in share price to $24.61, reflecting market optimism about its prospects.
- Portfolio Overview: JAN currently operates 34 senior housing communities with approximately 10,400 units across 10 states, including 15 Life Plan/CCRCs and 19 SHOP communities, showcasing its extensive footprint in the senior housing market.
- Financial Health: The company has no outstanding debt and approximately $1.4 billion in available liquidity post-IPO, enabling it to deploy IPO proceeds at attractive yields of 6-7% within the first year, demonstrating strong financial strength and growth potential.
- Earnings Expectations: KeyBanc established a normalized FFO estimate of $0.96 per share for 2026 and $1.13 for 2027, both exceeding the consensus estimates of $0.67 and $0.86, indicating JAN's profitability and growth outlook in the senior housing sector.
See More
Latest Rating Changes on Wall Street
- Infleqtion Coverage Initiation: Citigroup initiates coverage of quantum computing firm Infleqtion with a Buy/High Risk rating and a $20 price target, highlighting its uniqueness in the quantum computing sector, which may attract investor interest.
- SAP Downgrade: Piper Sandler downgrades SAP from Overweight to Neutral, citing challenges in the macroeconomic environment and anticipating lower valuation multiples as the software industry transitions from SaaS to AI.
- Positive Catalysts for Alphabet: Citigroup adds a 90-day Catalyst Watch on Alphabet, expecting upcoming product updates during events like Google Cloud Next and YouTube Brandcast to drive stock price appreciation.
- Biogen Upgrade: Piper Sandler upgrades Biogen from Neutral to Overweight, raising the price target from $177 to $214, reflecting confidence in its growth potential moving forward.
See More
Cantor Fitzgerald Initiates Coverage on JAN and SNDA with Overweight Rating
- Coverage Initiation: Cantor Fitzgerald has initiated coverage on Janus Living (JAN) and Sonida Senior Living (SNDA) with an Overweight rating, indicating analysts' optimistic outlook on the growth potential of these emerging companies.
- Market Opportunity Analysis: Analysts highlight that JAN and SNDA, focusing primarily on senior housing operations, provide unique investment opportunities for investors, particularly in a market dominated by large-cap REITs, filling a gap in the demand for pure-play senior housing platforms.
- Growth Potential Assessment: While large REITs require billions in investments to drive earnings growth, analysts believe JAN and SNDA could serve as more cost-effective investment alternatives amidst future market fluctuations due to their smaller market capitalizations.
- Rating Comparison: Despite Janus Living being rated Hold on Seeking Alpha and Sonida Senior Living also rated Hold by the Wall Street community and SA's Quant Ratings system, this reflects a cautious market sentiment towards both companies.
See More
IPO Market Faces Delays Amid Volatility
- Market Volatility Impact: The IPO market faced significant delays in the first quarter of 2026 due to tech sell-offs, tariff issues, private credit concerns, and ongoing conflicts in the Middle East, which caused a sharp decline in new issuances after a strong start.
- Decline in IPO Count: A total of 35 IPOs raised $9.9 billion this quarter, reflecting a drop in deal count from previous periods; however, 22 of these IPOs raised over $100 million, including Forgent, which raised over $1 billion, indicating sustained demand for larger offerings.
- Valuation Multiples Decline: The momentum from last year's tech IPO revival faded as valuation multiples collapsed amid fears of disruption from AI, yet investors still exhibited interest in the market, suggesting a cautious optimism for future opportunities.
- Future Outlook: Despite the current unstable market conditions, there remains investor interest in potential IPO opportunities, and it is anticipated that IPO activities may rebound as market conditions improve.
See More
Three IPOs Priced This Week with Market Insights
- Janus Living IPO: Janus Living (JAN) successfully raised $840 million at the high end of its pricing, achieving a market cap of $5.1 billion, with 36% of the offering backed by cornerstone investors, positioning the company to benefit from the aging population in its core markets despite climate risks.
- Swarmer's Strong Performance: Military drone software developer Swarmer (SWMR) raised $15 million and saw its stock surge over 500% on its first trading day and over 1000% on the second day, finishing the week up 634%, indicating robust demand in the drone software market.
- Guardian Metal Resources: Guardian Metal Resources (GMTL) raised $60 million with a market cap of $545 million, and while still in the early stages and unlikely to begin production for several years, its tungsten projects in Nevada hold potential long-term value.
- X-Energy IPO Pipeline: Nuclear tech company X-Energy (XE) has filed for a $100 million IPO, reflecting market demand for advanced nuclear reactors and fuel for electricity generation, thereby enhancing the diversity of the IPO market.
See More
Analysis of High-Yield Stocks in Healthcare Sector
- Perrigo's High Yield and Risks: With a forward dividend yield of 9.6%, Perrigo's stock has plummeted over 87.5% in the past decade, indicating the uncertainty behind its high yield, which investors must carefully assess as a potential value trap.
- Healthpeak's Restructuring Potential: As one of the largest healthcare REITs, Healthpeak Properties owns over 700 healthcare-related properties, currently offering a forward dividend yield of 7.1%, and its newly formed Janus Living could enhance its market value, attracting investors focused on capital growth.
- Dividend Cuts at Medical Properties Trust: Medical Properties Trust has a forward dividend yield of approximately 6.8%, but it has reduced its dividend twice due to the bankruptcy of major tenant Steward Health Care, highlighting its financial challenges.
- Financial Stability and Future Outlook: Despite facing tenant financial issues and over $2 billion in debt maturities, Medical Properties Trust's latest quarterly results show normalized funds from operations of $0.18 per share, suggesting it can sustain its current dividend for now.
See More
Janus Living Initiated with Buy Ratings, Shares Rise
- Rating Upgrade: Janus Living (JAN) was initiated with a Buy rating by BofA Securities and an Overweight rating by KeyBanc Capital Markets, resulting in a 2.58% increase in share price to $24.61, reflecting market optimism about its prospects.
- Portfolio Overview: JAN currently operates 34 senior housing communities with approximately 10,400 units across 10 states, including 15 Life Plan/CCRCs and 19 SHOP communities, showcasing its extensive footprint in the senior housing market.
- Financial Health: The company has no outstanding debt and approximately $1.4 billion in available liquidity post-IPO, enabling it to deploy IPO proceeds at attractive yields of 6-7% within the first year, demonstrating strong financial strength and growth potential.
- Earnings Expectations: KeyBanc established a normalized FFO estimate of $0.96 per share for 2026 and $1.13 for 2027, both exceeding the consensus estimates of $0.67 and $0.86, indicating JAN's profitability and growth outlook in the senior housing sector.
See More
Latest Rating Changes on Wall Street
- Infleqtion Coverage Initiation: Citigroup initiates coverage of quantum computing firm Infleqtion with a Buy/High Risk rating and a $20 price target, highlighting its uniqueness in the quantum computing sector, which may attract investor interest.
- SAP Downgrade: Piper Sandler downgrades SAP from Overweight to Neutral, citing challenges in the macroeconomic environment and anticipating lower valuation multiples as the software industry transitions from SaaS to AI.
- Positive Catalysts for Alphabet: Citigroup adds a 90-day Catalyst Watch on Alphabet, expecting upcoming product updates during events like Google Cloud Next and YouTube Brandcast to drive stock price appreciation.
- Biogen Upgrade: Piper Sandler upgrades Biogen from Neutral to Overweight, raising the price target from $177 to $214, reflecting confidence in its growth potential moving forward.
See More
Cantor Fitzgerald Initiates Coverage on JAN and SNDA with Overweight Rating
- Coverage Initiation: Cantor Fitzgerald has initiated coverage on Janus Living (JAN) and Sonida Senior Living (SNDA) with an Overweight rating, indicating analysts' optimistic outlook on the growth potential of these emerging companies.
- Market Opportunity Analysis: Analysts highlight that JAN and SNDA, focusing primarily on senior housing operations, provide unique investment opportunities for investors, particularly in a market dominated by large-cap REITs, filling a gap in the demand for pure-play senior housing platforms.
- Growth Potential Assessment: While large REITs require billions in investments to drive earnings growth, analysts believe JAN and SNDA could serve as more cost-effective investment alternatives amidst future market fluctuations due to their smaller market capitalizations.
- Rating Comparison: Despite Janus Living being rated Hold on Seeking Alpha and Sonida Senior Living also rated Hold by the Wall Street community and SA's Quant Ratings system, this reflects a cautious market sentiment towards both companies.
See More
IPO Market Faces Delays Amid Volatility
- Market Volatility Impact: The IPO market faced significant delays in the first quarter of 2026 due to tech sell-offs, tariff issues, private credit concerns, and ongoing conflicts in the Middle East, which caused a sharp decline in new issuances after a strong start.
- Decline in IPO Count: A total of 35 IPOs raised $9.9 billion this quarter, reflecting a drop in deal count from previous periods; however, 22 of these IPOs raised over $100 million, including Forgent, which raised over $1 billion, indicating sustained demand for larger offerings.
- Valuation Multiples Decline: The momentum from last year's tech IPO revival faded as valuation multiples collapsed amid fears of disruption from AI, yet investors still exhibited interest in the market, suggesting a cautious optimism for future opportunities.
- Future Outlook: Despite the current unstable market conditions, there remains investor interest in potential IPO opportunities, and it is anticipated that IPO activities may rebound as market conditions improve.
See More
Three IPOs Priced This Week with Market Insights
- Janus Living IPO: Janus Living (JAN) successfully raised $840 million at the high end of its pricing, achieving a market cap of $5.1 billion, with 36% of the offering backed by cornerstone investors, positioning the company to benefit from the aging population in its core markets despite climate risks.
- Swarmer's Strong Performance: Military drone software developer Swarmer (SWMR) raised $15 million and saw its stock surge over 500% on its first trading day and over 1000% on the second day, finishing the week up 634%, indicating robust demand in the drone software market.
- Guardian Metal Resources: Guardian Metal Resources (GMTL) raised $60 million with a market cap of $545 million, and while still in the early stages and unlikely to begin production for several years, its tungsten projects in Nevada hold potential long-term value.
- X-Energy IPO Pipeline: Nuclear tech company X-Energy (XE) has filed for a $100 million IPO, reflecting market demand for advanced nuclear reactors and fuel for electricity generation, thereby enhancing the diversity of the IPO market.
See More
